NFKB1 and glioblastoma: We observed moderate variations of the high basal levels of phospho-p65 NF-κB, phospho-AKT and phospho-ERK1/2 4 h after CBD treatment detected in both glioblastoma lines; these active levels were insensitive to co-treatment with AM251 (Figure 11A).